Show items per page
Elements: 9
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors Quattrini, Giulia; Pievani, Michela; Jovicich, Jorge; Aiello, Marco; ... Marizzoni, Moira 2020
add to browser selection
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status Marizzoni, Moira; Ferrari, Clarissa; Babiloni, Claudio; Albani, Diego; ... Frisoni, Giovanni 2020
add to browser selection
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study van Maurik, Ingrid S; Vos, Stephanie J; Bos, Isabelle; Bouwman, Femke H; ... van der Flier, Wiesje M 2019
add to browser selection
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study Kalman, Janos L; Papiol, Sergi; Forstner, Andreas J; Heilbronner, Urs; ... Schulze, Thomas G 2019
add to browser selection
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Marizzoni, Moira; Ferrari, Clarissa; Macis, Ambra; Jovicich, Jorge; ... Frisoni, Giovanni 2019
add to browser selection
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study Albani, Diego; Marizzoni, Moira; Ferrari, Clarissa; Fusco, Federica; ... Frisoni, Giovanni 2018
add to browser selection
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) Nathan, Pradeep J; Lim, Yen Ying; Abbott, Rosemary; Galluzzi, Samantha; ... Frisoni, Giovanni 2017
add to browser selection
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type Popp, Julius; Wolfsgruber, Steffen; Heuser, Isabella; Peters, Oliver; ... Jessen, Frank 2015
add to browser selection
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial Dodel, Richard; Rominger, Axel; Bartenstein, Peter; Barkhof, Frederik; ... Jessen, Frank 2013